<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>General Science Articles</title>
  <link rel="stylesheet" href="../static/base.css">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <style>
    @media (max-width: 600px) {
      body {
        padding: 10px;
        font-size: 16px;
      }
      h1 {
        font-size: 24px;
      }
    }
  </style>
</head>
<body>
  <h1>General Science</h1>

  <div class="article">
    <h3>WHO's GLASS 2025 Report on AMR</h3>
    <p><em>20-11-2025</em></p>
    <div class="social-shares">
<div class="a2a_kit a2a_kit_size_32 a2a_default_style">
<a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_google_plus"></a>
<a class="a2a_button_telegram"></a>
<a class="a2a_dd a2a_counter" href="https://www.addtoany.com/share"></a>
</div>
</div><div class="border-bg" style="background-color: #ffdbdb; border-radius: 20px; padding: 20px;">
<p><b>For Prelims:</b> <a href="/important-institutions/drishti-specials-important-institutions-international-institution/world-health-organization-who" rel="noopener" target="_blank"><b>World Health Organization (WHO)</b></a><span style="font-weight: 400;">, </span><a href="/daily-updates/daily-news-analysis/antibiotics-resistance" rel="noopener" target="_blank"><b>Antibiotics</b></a><span style="font-weight: 400;">, </span><a href="/daily-updates/daily-news-analysis/government-bans-14-combination-drugs" rel="noopener" target="_blank"><b>Fixed Dose Combinations (FDCs)</b></a><span style="font-weight: 400;">, </span><a href="/daily-updates/daily-news-analysis/genome-sequencing-4" rel="noopener" target="_blank"><b>Genomic Sequencing</b></a><span style="font-weight: 400;">, </span><a href="/daily-updates/daily-news-analysis/india-s-amr-crisis" rel="noopener" target="_blank"><b>Schedule H1</b></a><span style="font-weight: 400;">.</span></p>
<p><b>For Mains:</b><span style="font-weight: 400;"> Key Insights from WHO’s GLASS 2025 Report: Antimicrobial Resistance, Implications, Actions Taken, and Future Measures to Combat AMR.</span></p>
</div><p><a href="https://www.thehindu.com/news/national/holding-upglass-to-india-securing-stewardship-to-tackle-amr/article70272630.ece" rel="noopener" target="_blank"><b>Source: TH</b></a></p><h2><span style="font-weight: 400;">Why in News?</span></h2><p><span style="font-weight: 400;">The </span><a href="/important-institutions/drishti-specials-important-institutions-international-institution/world-health-organization-who" rel="noopener" target="_blank"><b>World Health Organization (WHO)</b></a><span style="font-weight: 400;"> released its </span><a href="/daily-updates/daily-news-analysis/antimicrobial-resistance-11" rel="noopener" target="_blank"><b>Global Antibiotic Resistance Surveillance Report (GLASS)</b></a><b> 2025</b><span style="font-weight: 400;">, highlighting that India has </span><b>one of the highest antimicrobial resistance (AMR) rates</b><span style="font-weight: 400;"> globally, with </span><b>1 in 3 bacterial infections resistant</b><span style="font-weight: 400;"> to common antibiotics.</span></p><h2><span style="font-weight: 400;">What are the Key Findings of the GLASS 2025 Report?</span></h2><ul style="list-style-type: square;">
<li><b>Rising AMR Threat:</b><span style="font-weight: 400;"> Between 2018 and 2023, </span><b>AMR</b><span style="font-weight: 400;"> increased in 40% of monitored pathogen-antibiotic combinations, notably against critical </span><b>“Watch” antibiotics</b><span style="font-weight: 400;"> like </span><b>carbapenems</b><span style="font-weight: 400;"> and </span><b>fluoroquinolones.</b><b></b></li>
<li><b>Geographically Uneven AMR: AMR<span style="font-weight: 400;"> was highest in </span>Southeast Asia<span style="font-weight: 400;"> and the </span>Eastern Mediterranean<span style="font-weight: 400;">, followed by </span>Africa<span style="font-weight: 400;">, while </span>Europe<span style="font-weight: 400;"> and the </span>Western Pacific<span style="font-weight: 400;"> show lower rates.</span></b></li>
<li><b>AMR Threat in India: </b><span style="font-weight: 400;">In 2023, India, with one of the highest </span><b>AMR rates</b><span style="font-weight: 400;">, had 1 in 3</span> <span style="font-weight: 400;">bacterial infections resistant to common antibiotics, with </span><b>ICU infections</b><span style="font-weight: 400;"> by </span><b>E. coli</b><span style="font-weight: 400;">, </span><b>K. pneumoniae</b><span style="font-weight: 400;">, and </span><b>S. aureus</b><span style="font-weight: 400;"> highly resistant.</span></li>
</ul><h2><span style="font-weight: 400;">What is Antimicrobial Resistance (AMR)?</span></h2><ul style="list-style-type: square;">
<li><b>About: AMR</b><span style="font-weight: 400;"> is a phenomenon where </span><b>bacteria, viruses, fungi, and parasites</b><span style="font-weight: 400;"> evolve over time and no longer respond to </span><b>medicines</b><span style="font-weight: 400;"> (like </span><b>antibiotics, antivirals, and antifungals</b><span style="font-weight: 400;">) designed to kill them.</span><b></b></li>
<li><b>AMR as a Health Threats:</b>
<ul style="list-style-type: circle;">
<li><b>Pandemic-Level Risk:</b><span style="font-weight: 400;"> AMR makes infections harder to treat, increasing the difficulty of managing common illnesses and making medical procedures, such as surgeries, significantly riskier. </span>
<ul style="list-style-type: disc;">
<li><span style="font-weight: 400;">According to the </span><b>World Bank</b><span style="font-weight: 400;">, by 2050, unchecked </span><b>AMR</b><span style="font-weight: 400;"> could cause </span><b>economic damage</b><span style="font-weight: 400;"> comparable to the </span><b>2008 financial crisis</b><span style="font-weight: 400;">.</span></li>
</ul>
</li>
<li><b>Untreatable Infections:</b><span style="font-weight: 400;"> Common </span><b>infections</b><span style="font-weight: 400;"> (like </span><b>pneumonia, tuberculosis, and sepsis</b><span style="font-weight: 400;">) could become </span><b>fatal</b><span style="font-weight: 400;">. </span>
<ul style="list-style-type: disc;">
<li><span style="font-weight: 400;">Bacterial AMR was directly responsible for </span><b>1.27 million deaths (in 2019) </b><span style="font-weight: 400;">and contributed to nearly five million deaths worldwide.</span></li>
</ul>
</li>
<li><b>End of Modern Medicine:</b><span style="font-weight: 400;"> Routine procedures (like </span><b>surgery, chemotherapy, and organ transplants</b><span style="font-weight: 400;">) become </span><b>high-risk</b><span style="font-weight: 400;"> due to untreatable infections.</span></li>
</ul>
</li>
</ul><p><a href="http://drishtiias.com/images/uploads/1763629289_amr.png" rel="noopener" target="_blank" title="AMR"><span style="font-weight: 400;"><img caption="false" class="content-img" height="702" src="http://drishtiias.com/images/uploads/1763629289_amr.png" style="display: block; margin-left: auto; margin-right: auto;" width="721"/></span></a></p><h2><span style="font-weight: 400;">What are Driving Factors Behind the Rise of Antimicrobial Resistance in India?</span></h2><ul style="list-style-type: square;">
<li><b>Excessive Antibiotic Usage:</b><span style="font-weight: 400;"> Widespread </span><a href="/daily-updates/daily-news-analysis/antibiotics-resistance" rel="noopener" target="_blank"><b>antibiotics</b></a><b> misuse</b><span style="font-weight: 400;"> in India—including </span><b>over-the-counter sales, self-medication, and incomplete treatments</b><span style="font-weight: 400;">—fuels </span><b>AMR</b><span style="font-weight: 400;">, with 59% of 2022 use from WHO’s </span><b>“Watch” category</b><span style="font-weight: 400;"> for serious infections.</span><b> </b></li>
<li><b>Poor Healthcare System:</b><span style="font-weight: 400;"> Limited diagnostics, </span><b>weak regulatory enforcement </b><span style="font-weight: 400;">and</span><b> unevenness across states</b><span style="font-weight: 400;">, along with </span><b>overcrowded hospitals</b><span style="font-weight: 400;"> and poor hygiene, fuel empirical antibiotic use and spread </span><b>resistant pathogens</b><span style="font-weight: 400;">.</span></li>
<li><b>Stagnation in Antibiotic Development:</b> <b>Nafithromycin (2024)</b><span style="font-weight: 400;"> is the first new antibiotic in its class in over 30 years, as pharmaceutical companies prioritized </span><b>profitable chronic disease treatments</b><span style="font-weight: 400;">, limiting options against </span><b>resistant pathogens</b><span style="font-weight: 400;">.</span></li>
<li><b>Pervasive Non-Human Applications:</b><span style="font-weight: 400;"> India is the world’s </span><b>4</b><b>th</b><b>-largest consumer of animal antimicrobials</b><span style="font-weight: 400;">, with use in </span><b>animal feed</b><span style="font-weight: 400;"> projected to rise </span><b>82% by 2030</b><span style="font-weight: 400;">. </span>
<ul style="list-style-type: circle;">
<li><span style="font-weight: 400;">Indiscriminate use in </span><b>agriculture and aquaculture</b><span style="font-weight: 400;"> spreads </span><b>resistant genes</b><span style="font-weight: 400;"> into the </span><b>food chain </b><span style="font-weight: 400;">worsening </span><b>AMR</b><span style="font-weight: 400;">.</span></li>
</ul>
</li>
<li><b>Environmental Contamination:</b><span style="font-weight: 400;"> Environmental contamination from </span><b>pharma waste</b><span style="font-weight: 400;"> and </span><b>untreated hospital effluents</b><span style="font-weight: 400;">, combined with </span><b>poor sewage and waste management</b><span style="font-weight: 400;">, creates </span><b>hotspots</b><span style="font-weight: 400;"> that promote the development and spread of </span><b>AMR</b><span style="font-weight: 400;">. </span></li>
</ul><div class="border-bg">
<h2><span style="font-weight: 400;">Initiatives Taken to Tackle AMR</span></h2>
<h2><span style="font-weight: 400;">India</span></h2>
<ul style="list-style-type: square;">
<li><b>Drugs and Cosmetics Rules, 1945:</b><span style="font-weight: 400;"> It combats </span><b>AMR</b><span style="font-weight: 400;"> by ensuring </span><b>antibiotic quality</b><span style="font-weight: 400;"> via </span><b>Schedule M (Good Manufacturing Practices)</b><span style="font-weight: 400;"> and promoting </span><b>rational use</b><span style="font-weight: 400;"> through </span><b>prescription-only rules</b><span style="font-weight: 400;"> under </span><b>Schedules H and H1</b><span style="font-weight: 400;">.</span></li>
<li><b>ICMR's AMR Surveillance and Research Network:</b><span style="font-weight: 400;"> It tracks </span><b>drug-resistant infections</b><span style="font-weight: 400;"> in 30 </span><b>tertiary hospitals</b><span style="font-weight: 400;">.</span></li>
<li><b>National Action Plan on AMR 2017:</b><span style="font-weight: 400;"> It promotes a </span><a href="/daily-updates/daily-news-analysis/one-health-concept-1" rel="noopener" target="_blank"><b>One Health approach</b></a><span style="font-weight: 400;"> involving multiple </span><b>stakeholder ministries</b><span style="font-weight: 400;">. </span></li>
<li><b>National Programme on AMR containment 2012: </b><span style="font-weight: 400;">AMR Surveillance Network strengthened through </span><b>labs in State Medical Colleges</b><span style="font-weight: 400;">.</span></li>
<li><b>Antibiotic Stewardship Program (AMSP):</b><span style="font-weight: 400;"> It seeks to curb </span><b>antibiotic misuse</b><span style="font-weight: 400;"> in </span><b>hospitals/ICUs</b><span style="font-weight: 400;"> and has resulted in the </span><b>ban of 40 inappropriate </b><a href="/daily-updates/daily-news-analysis/government-bans-14-combination-drugs" rel="noopener" target="_blank"><b>Fixed Dose Combinations (FDCs)</b></a><span style="font-weight: 400;">. </span></li>
</ul>
<h2><span style="font-weight: 400;">Global</span></h2>
<ul style="list-style-type: square;">
<li><b>WHO Global Action Plan on AMR (2015):</b><span style="font-weight: 400;"> It is a strategic blueprint to combat AMR. It focuses on five objectives: </span><b>raising awareness</b><span style="font-weight: 400;">, </span><b>strengthening surveillance and research</b><span style="font-weight: 400;">, </span><b>reducing infections</b><span style="font-weight: 400;">, </span><b>optimizing antimicrobial use</b><span style="font-weight: 400;">, and </span><b>ensuring sustainable investment</b><span style="font-weight: 400;"> in new medicines, diagnostics, and vaccines.</span></li>
<li><b>World Antimicrobial Awareness Week (WAAW, 18 – 24 November):</b><span style="font-weight: 400;"> Held since 2015, </span><b>WAAW</b><span style="font-weight: 400;"> is a global campaign to raise </span><b>AMR awareness</b><span style="font-weight: 400;"> and promote </span><b>best practices</b><span style="font-weight: 400;"> among the public, health workers, and policymakers.</span></li>
<li><b>Global Antimicrobial Resistance and Use Surveillance System (GLASS):</b><span style="font-weight: 400;"> Launched in 2015, </span><b>WHO's GLASS</b><span style="font-weight: 400;"> collects </span><b>AMR data</b><span style="font-weight: 400;"> from humans, antimicrobial use, the </span><b>food chain</b><span style="font-weight: 400;">, and the </span><b>environment</b><span style="font-weight: 400;"> to guide strategies.</span></li>
</ul>
</div><h2>What Measures can India Take to Curb the Rise of AMR?</h2><ul style="list-style-type: square;">
<li><b>Mandate Hospital Stewardship:</b><span style="font-weight: 400;"> India can curb </span><b>AMR</b><span style="font-weight: 400;"> by implementing </span><b>AMSPs</b><span style="font-weight: 400;">, auditing </span><b>prescriptions</b><span style="font-weight: 400;">, training </span><b>healthcare staff</b><span style="font-weight: 400;">, adopting </span><b>digital prescribing tools</b><span style="font-weight: 400;">, and encouraging </span><b>rapid diagnostics</b><span style="font-weight: 400;">.</span>
<ul style="list-style-type: circle;">
<li><span style="font-weight: 400;">Scale up </span><b>Indian Council of Medical Research’s </b><a href="/daily-updates/daily-news-analysis/antimicrobial-resistance-11" rel="noopener" target="_blank"><b>AMR Surveillance Network</b></a><span style="font-weight: 400;">, use </span><a href="/daily-updates/daily-news-analysis/genome-sequencing-4" rel="noopener" target="_blank"><b>genomic sequencing</b></a><span style="font-weight: 400;">, and align with </span><b>GLASS</b><span style="font-weight: 400;"> for standardized data on AMR.</span></li>
</ul>
</li>
<li><b>Curb Over-the-Counter Sales: </b><span style="font-weight: 400;">Enforce</span><a href="/daily-updates/daily-news-analysis/india-s-amr-crisis" rel="noopener" target="_blank"> <b>Schedule H1</b></a><span style="font-weight: 400;"> (restricts sale of certain antibiotics without prescription), track </span><b>antibiotic sales digitally</b><span style="font-weight: 400;">, inspect pharmacies, and run </span><b>public awareness campaigns</b><span style="font-weight: 400;"> on self-medication risks.</span></li>
<li><b>Strict implementations of Drugs and Cosmetics Rules, 1945:</b> <b>Ban</b><span style="font-weight: 400;"> antibiotics as</span><b> growth promoters</b><span style="font-weight: 400;">, set up </span><b>agricultural antibiotic surveillance</b><span style="font-weight: 400;">, and promote alternatives like</span><b> probiotics</b><span style="font-weight: 400;">.</span></li>
<li><b>Control Pharmaceutical Pollution:</b><span style="font-weight: 400;"> Mandate </span><b>advanced wastewater treatment</b><span style="font-weight: 400;">, promote </span><b>green pharmacy certification</b><span style="font-weight: 400;">, set </span><b>industry best practices</b><span style="font-weight: 400;">, and fund </span><b>effluent treatment research</b><span style="font-weight: 400;">.</span></li>
</ul><h2><span style="font-weight: 400;">Conclusion</span></h2><p><span style="font-weight: 400;">India's </span><b>AMR crisis</b><span style="font-weight: 400;"> spans humans, animals, and environment; tackling it requires </span><b>stewardship</b><span style="font-weight: 400;">, </span><b>regulation</b><span style="font-weight: 400;">, </span><b>environmental controls</b><span style="font-weight: 400;">, </span><b>surveillance</b><span style="font-weight: 400;">, </span><b>public awareness</b><span style="font-weight: 400;">, and alignment with </span><b>GLASS</b><span style="font-weight: 400;"> and </span><b>One Health</b><span style="font-weight: 400;">.</span></p><table border="1" style="width: 100%; border-collapse: collapse; border-style: dotted; border-color: #000000; background-color: #f5fbff;">
<tbody>
<tr>
<td style="width: 100%;">
<p><em><span style="text-decoration: underline;"><b>Drishti Mains Question:</b></span></em></p>
<p><b>Q.</b><span style="font-weight: 400;"> "Antimicrobial Resistance (AMR) is not just a health issue but also an environmental and agricultural one." Elucidate with special reference to India. What robust regulatory measures are needed across these sectors?</span></p>
</td>
</tr>
</tbody>
</table><div class="border-bg">
<h2><span style="font-weight: 400;">Frequently Asked Questions (FAQs)</span></h2>
<p><b>1. What is the current AMR situation in India according to GLASS 2025?</b></p>
<p><span style="font-weight: 400;">India has one of the highest AMR rates globally, with one in three bacterial infections resistant to common antibiotics.</span></p>
<p><b>2. Which antibiotics are showing rising resistance in India?</b></p>
<p><span style="font-weight: 400;">Critical "Watch" antibiotics such as carbapenems and fluoroquinolones are increasingly ineffective against Gram-negative pathogens like E. coli, K. pneumoniae, and Acinetobacter spp.</span></p>
<p><b>3. What strategies has India implemented to tackle AMR?</b></p>
<p><span style="font-weight: 400;">National AMR action plans, hospital antibiotic stewardship programs, ICMR surveillance, and bans on inappropriate Fixed Dose Combinations (FDCs).</span></p>
</div><p style="text-align: center;"><iframe allowfullscreen="allowfullscreen" height="314" src="//www.youtube.com/embed/vQnJIYU_Oek" width="560"></iframe></p><div class="border-bg" style="background-color: #fdedec; border-radius: 20px; padding: 20px;">
<h2 style="text-align: center;"><span style="font-weight: 400;">UPSC Civil Services Examination, Previous Year Questions (PYQ)</span></h2>
<h2><em><span style="text-decoration: underline;">Prelims</span></em></h2>
<p><span style="font-weight: 400;"><strong>Q.</strong> Which of the following are the reasons for the occurrence of multi-drug resistance in microbial pathogens in India? (2019)</span></p>
<ol>
<li><span style="font-weight: 400;">Genetic predisposition of some people</span></li>
<li><span style="font-weight: 400;">Taking incorrect doses of antibiotics to cure diseases</span></li>
<li><span style="font-weight: 400;">Using antibiotics in livestock farming</span></li>
<li><span style="font-weight: 400;">Multiple chronic diseases in some people</span></li>
</ol>
<p><span style="font-weight: 400;">Select the correct answer using the code given below.</span></p>
<p><span style="font-weight: 400;">(a) 1 and 2</span></p>
<p><span style="font-weight: 400;">(b) 2 and 3 only</span></p>
<p><span style="font-weight: 400;">(c) 1, 3 and 4</span></p>
<p><span style="font-weight: 400;">(d) 2, 3 and 4</span></p>
<p><span style="font-weight: 400;">Ans: (b)</span></p>
<hr>
<h2><em><span style="text-decoration: underline;">Mains</span></em></h2>
<p><span style="font-weight: 400;"><strong>Q.</strong> Can overuse and free availability of antibiotics without Doctor’s prescription, be contributors to the emergence of drug-resistant diseasesin India? What are the available mechanisms for monitoring and control? Critically discuss the various issues involved. (2014)</span></p>
</hr></div><br/><br/><div class="banner-static">
<div class="slider">
<div>
<!-- <a class="desktop-ad-banner" href="https://www.drishtiias.com/prelims/gs-foundation-classroom-course" target="_blank"><img src="https://www.drishtiias.com/drishti/img/Offline-batch-karol-bagh-cover-page-web.png" class="for-desktop" alt=""></a> -->
<!-- <a class="mobile-ad-banner" href="https://www.drishtiias.com/prelims/gs-foundation-classroom-course" target="_blank"><img src="https://www.drishtiias.com/drishti/img/Offline-batch-karol-bagh-cover-page-web.png" alt=""></a> -->
</div>
</div>
</div>
  </div>

</body>
</html>
